Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET.
Sebastian-Valles F, Sánchez de la Blanca Carrero N, Rodríguez-Laval V, Martinez-Hernández R, Serrano-Somavilla A, Knott-Torcal C, Muñoz de Nova JL, Martín-Pérez E, Marazuela M, Sampedro-Nuñez MA. Sebastian-Valles F, et al. Among authors: marazuela m. Cancers (Basel). 2022 Oct 22;14(21):5189. doi: 10.3390/cancers14215189. Cancers (Basel). 2022. PMID: 36358607 Free PMC article.
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
Figueroa-Vega N, Díaz A, Adrados M, Alvarez-Escolá C, Paniagua A, Aragonés J, Martín-Pérez E, Leskela S, Moreno-Otero R, González-Amaro R, Marazuela M. Figueroa-Vega N, et al. Among authors: marazuela m. Endocr Relat Cancer. 2010 Oct 5;17(4):897-908. doi: 10.1677/ERC-10-0020. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20696814
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
Martin-Perez E, Capdevila J, Castellano D, Jimenez-Fonseca P, Salazar R, Beguiristain-Gomez A, Alonso-Orduña V, Martinez Del Prado P, Villabona-Artero C, Diaz-Perez JA, Monleon A, Marazuela M, Pachon V, Sastre-Valera J, Sevilla I, Castaño A, Garcia-Carbonero R. Martin-Perez E, et al. Among authors: marazuela m. Neuroendocrinology. 2013;98(2):156-68. doi: 10.1159/000355152. Epub 2013 Sep 19. Neuroendocrinology. 2013. PMID: 23988576
Cabergoline treatment in acromegaly: pros.
Marazuela M, Ramos-Leví A, Sampedro-Núñez M, Bernabeu I. Marazuela M, et al. Endocrine. 2014 Jun;46(2):215-9. doi: 10.1007/s12020-014-0206-1. Epub 2014 Feb 16. Endocrine. 2014. PMID: 24532103
Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells.
Leskela S, Serrano A, de la Fuente H, Rodríguez-Muñoz A, Ramos-Levi A, Sampedro-Nuñez M, Sánchez-Madrid F, González-Amaro R, Marazuela M. Leskela S, et al. Among authors: marazuela m. PLoS One. 2015 Apr 16;10(4):e0123938. doi: 10.1371/journal.pone.0123938. eCollection 2015. PLoS One. 2015. PMID: 25880730 Free PMC article.
In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters.
Luque RM, Sampedro-Nuñez M, Gahete MD, Ramos-Levi A, Ibáñez-Costa A, Rivero-Cortés E, Serrano-Somavilla A, Adrados M, Culler MD, Castaño JP, Marazuela M. Luque RM, et al. Among authors: marazuela m. Oncotarget. 2015 Aug 14;6(23):19619-33. doi: 10.18632/oncotarget.4316. Oncotarget. 2015. PMID: 26124083 Free PMC article.
Long-term treatment with pegvisomant for acromegaly: a 10-year experience.
Ramos-Leví AM, Bernabeu I, Álvarez-Escolá C, Aller J, Lucas T, de Miguel P, Rodríguez-Cañete L, Sampedro-Núñez MA, Halperin I, Puig-Domingo M, Marazuela M. Ramos-Leví AM, et al. Among authors: marazuela m. Clin Endocrinol (Oxf). 2016 Apr;84(4):540-50. doi: 10.1111/cen.12993. Epub 2016 Jan 26. Clin Endocrinol (Oxf). 2016. PMID: 26662620
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
Sampedro-Núñez M, Luque RM, Ramos-Levi AM, Gahete MD, Serrano-Somavilla A, Villa-Osaba A, Adrados M, Ibáñez-Costa A, Martín-Pérez E, Culler MD, Marazuela M, Castaño JP. Sampedro-Núñez M, et al. Among authors: marazuela m. Oncotarget. 2016 Feb 9;7(6):6593-608. doi: 10.18632/oncotarget.6565. Oncotarget. 2016. PMID: 26673010 Free PMC article. Clinical Trial.
216 results